Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 2Recruiting 1Completed 1

Sponsor Class

NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 10Genitourinary 8Sarcoma 2Head & Neck 2Tumor-Agnostic 1

Conditions

Sarcoma 2

Interventions

Cyclophosphamide 26Temozolomide 23Doxorubicin 22Radiotherapy 21Filgrastim 19Ifosfamide 15pazopanib 14Gemcitabine 14Etoposide 13Bevacizumab 13Irinotecan 12Cisplatin 12Magnetic Resonance Spectroscopy 11Imatinib Mesylate 11Granulocyte Colony-Stimulating Factor 11Carboplatin 11Radiation 9Methotrexate 9pembrolizumab 8fludarabine phosphate 8Rituximab 8Paclitaxel 8Docetaxel 8Cyclosporine 8Busulfan 8Antilymphocyte Serum 8fludarabine 7Vincristine 7Radiotherapy, Intensity-Modulated 7Mycophenolic Acid 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Mitomycin × Sarcoma × Clear all
NCT00002993 2013-07-09

Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus

GOG Foundation

Phase 2 Terminated
30 enrolled
Sarcoma

Sarcoma

NCT00033644 2013-04-11

Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus

GOG Foundation

Phase 2 Terminated
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡